LENZ Therapeutics
LENZ
60 hedge funds and large institutions have $587M invested in LENZ Therapeutics in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 20 closing their positions.
45% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 20
18% more funds holding
Funds holding: 51 → 60 (+9)
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
0.63% more ownership
Funds ownership: 8.21% → 8.85% (+0.63%)
40% less capital invested
Capital invested by funds: $981M → $587M (-$394M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$52.6M |
| 2 |
BlackRock
New York
|
+$17.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.1M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$10.7M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
-$30.5M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.22M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$6.2M |
| 4 |
Goldman Sachs
New York
|
-$4.24M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$3.84M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$452K | -2,100 | Closed |
|
|
MS
77
Maven Securities
St Helier,
Jersey
| – | -$389K | -1,786 | Closed |
|
78
Tudor Investment Corp
Stamford,
Connecticut
| – | -$369K | -1,714 | Closed |
|
|
VF
79
Virtu Financial
New York
| – | -$237K | -1,101 | Closed |
|
|
PHK
80
Point72 Hong Kong
Hong Kong
| – | -$79K | -368 | Closed |
|
LENZ Hedge Fund Activity: Q3 2021 in Review
60 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in LENZ Therapeutics (LENZ) for Q3 2021, worth a combined $587M — down 40% from $981M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new LENZ positions and 20 closed out — a net gain of 9 holders — while 12 added to existing stakes and 11 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $52.6M. The largest seller was SB Management, exiting entirely with an estimated $30.5M sold.
- 60 institutional investors held LENZ Therapeutics (LENZ) as of Q3 2021, up from 51 in Q2 2021.
- Funds reported $587M of LENZ Therapeutics stock for Q3 2021, down 40% quarter-over-quarter.
- 29 funds opened new LENZ Therapeutics positions in Q3 2021 and 20 closed out, a net change of +9 holders.
- The largest LENZ Therapeutics buyer in Q3 2021 was Fidelity Investments, an estimated $52.6M added.
- The largest LENZ Therapeutics seller in Q3 2021 was SB Management, an estimated $30.5M sold.
Based on aggregated 13F filings for Q3 2021.